were no true adverse effects related to the recall are very low which means there are no injuries reported The pharmaceutical company Ranbaxy is recalling bottles of 10‚ 20‚ and 40 milligram tablets atorvastatin calcium‚ the generic version of Lipitor. The FDA granted the company approval of the manufacture of drug in New Jersey in 2011. Ranbaxy has been under the radar since 2006 for submitting false data to FDA and barred the company from manufacturing drugs in the United States until they
Premium Medicine Pharmacology Pharmaceutical drug
protection. Pfizer has many competing technologies in the market place for such diseases as cardiac health‚ mental health‚ and infectious disease treatments. Their drug Lipitor is by far the highest grossing drug the company currently has on the market. Cardiac disease is the most common and fatal disease that Americans face. Lipitor functions by lowering low density lipids (or fats) in the blood stream thus promoting cardiac and circulatory efficiency and health. Pfizer’s
Premium Company Amino acid Pharmacology
In United States‚ we have a major problem with the addiction of prescription drugs. “Prescription drugs are playing an increasingly larger role in U.S. life‚ with nearly half of all Americans taking one or more medications” (Thompson 2013-2014). “Since I went to pharmacy school‚ I learned Drug Enforcement Administration’s (DEA) and FDA rules and regulation which made me wonder about how and why misuse and abuse of prescription drugs costs the country an estimated of $53.4 billion‚ which is very
Premium Pharmacology United States Drug addiction
traction for manufacturing new drugs‚ and in turn Orchid will be able to access its strong distribution network. The launch of a generic version of Imitrex in Dec’08‚ which is still in an FTF status‚ will boost the Company’s sales in CY09E. Apart from Lipitor‚ Nexium will contribute around USD 1.5 bn revenues over 2009-2014. However‚ we have not included this in our projections for CY09E. We expect the revenue to 35 18 23 24 grow at a CAGR of 15.4% for CY07-09E. During the quarter‚ Ranbaxy demerged
Premium Ranbaxy Laboratories Revenue Generic drug
Consumer Needs‚ Marketing Daily. Retrieved from: http://www.mediapost.com/publications/article/193289/study-google-facebook-walmart-fill-consumer-nee.html#ixzz2T0sJuAz9 Loftus‚ J (April 2013).Pfizer 1st-Quarter Profit‚ Sales Miss Estimates as Lipitor Pressure Continues‚ The Wall Street Journal. Retrieved from: http://online.wsj.com/article/BT-CO-20130430-714942.html Hughes‚ D (May 2012). BrandZ-Top 100 Most Valuable Brands Study 2012‚ Millward Brown Press Release. Retrieved from: http://www
Premium Maslow's hierarchy of needs Brand Branding
force for sales growth for new or already launched products. Some weaknesses Pfizer will have to improve on are a heavy reliance on Lipitor and explosive growth to generic erosion (Market Line‚ 2013‚ p. 26). Pfizer dominated the globe with sales of the medication Lipitor‚ however; by the mid-2006 a generic impact has slowed sales. “With patent expiry Lipitor is exposed to generic competition‚ which could have a significant impact on the overall performance of the company”
Premium Health care Pharmaceutical industry
CC Follow up diabetes‚ hypertension‚ potential sleep apnea‚ back pain. S The patient once again‚ has not been taking care of himself. He states he has not been exercising like he knows he should‚ he is not eating well. He is not taking his medications as prescribed. He is only taking his metformin ER 500 mg two tablets with dinner four days per week instead of taking it two tablets twice a day‚ daily. He is also not taking his NovoLog sliding scale. He does tell me he takes his Lantus 50 units
Premium Nutrition Obesity Dieting
Presentation on: Pfizer and the Pharmaceutical Industry Fletcher Leung Analyst Investment Analysis Group February 15‚ 2002 Presentation Agenda • Industry Overview: Research Based Pharmaceuticals • Pfizer – Company Specifics – Performance – Growth Drivers • Valuation – Comparables Analysis – DCF • Recommendation February 15‚ 2002 Page 2 Investment Analysis Group 1 Industry Overview Economic •Cost Effective Demographic Sociocultural •Aging Population
Premium
expired. In December 2005‚ Ranbaxy’s shares were hit hard by a patent ruling disallowing production of its own version of Pfizer’s cholesterol-cutting drug Lipitor‚ which has annual sales of more than $10 billion.[3] In June 2008‚ Ranbaxy settled the patent dispute with Pfizer allowing them to sell Atorvastatin Calcium‚ the generic version of Lipitor(R)and Atorvastatin Calcium-Amylodipine Besylate‚ the generic version of Pfizer’s Caduet(R) in the US starting November 30‚ 2011. The settlement also resolved
Premium Ranbaxy Laboratories Generic drug
Pharmaceutical Marketing Merck “Merck has gone beyond developing and selling prescription pharmaceuticals. It formed joint ventures in 1989 with Johnson & Johnson to sell over the-counter pharmaceuticals; in 1991 with DuPont to expand basic research‚ and in 2000 with Scherigng-Plough to develop and market new prescriptions medicines. In 1997‚ Merck and Rhone-Poulenc S.A. (now Sanofi-Aventis S.A.) combined animal health and poultry genetics business to form Merial Limited‚ a fully integrated
Premium Pharmaceutical industry Pharmacology Clinical trial